Filing Flows › Enovix (ENVX) › Q1 2026 › vs Q1 2025
Enovix (ENVX) Q1 2026 vs Q1 2025 (year over year)
Enovix's revenue rose $2.5M (+49%) from $5.1M in Q1 2025 to $7.6M in Q1 2026.
Enovix, Q1 2026: revenue $7.6M (+49% year over year), operating margin -577.6%, net loss $38.3M, operating cash flow −$33.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $7.6M | $5.1M | $2.5M | +49% |
| Other income, net | $5.5M | $18.9M | −$13.4M | -71% |
| Income tax benefit | $129K | $162K | −$33K | -20% |
| Net loss | $38.3M | $23.5M | $14.7M | +63% |
| Costs & expenses | $51.5M | $47.7M | $3.8M | +8% |
| Operating costs | $51.5M | $47.7M | $3.8M | +8% |
| Cost of revenue | $6.0M | $4.8M | $1.2M | +25% |
| Research & development | $26.5M | $25.9M | $599K | +2% |
| SG&A | $18.9M | $16.9M | $2.0M | +12% |
| Operating cash sources | $54.2M | $37.4M | $16.8M | +45% |
| Depreciation & amortization | $9.4M | $8.4M | $922K | +11% |
| Share-based compensation | $11.8M | $12.0M | −$249K | -2% |
| Cash used in operations | $33.1M | $16.9M | $16.2M | +96% |
| Net loss absorbed | $38.3M | $23.5M | $14.7M | +63% |
| Working capital & other | $15.9M | $13.8M | $2.1M | +15% |
Questions
How much did Enovix's revenue grow year over year in Q1 2026?
Enovix's revenue rose $2.5M (+49%) from $5.1M in Q1 2025 to $7.6M in Q1 2026.